Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities
2021 · Nature Communications · 124 citations
https://doi.org/10.1038/s41467-021-22140-0
A
Andriy Derkach
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
388
Papers
3.8K
Citations
32
h-index
70
i10-index
Andriy Derkach is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Acute Myeloid Leukemia Research & Myeloproliferative Neoplasms: Diagnosis and Treatment. The author has an h-index of 32, co-authored 330 publications.
ORCID: 0000-0003-2178-8493Papers by this author
worksMolecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg Cells
2023 · Blood Cancer Discovery · 55 citations
https://doi.org/10.1158/2643-3230.bcd-22-0128
Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma
2021 · Nature Communications · 46 citations
https://doi.org/10.1038/s41467-021-25469-8
Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
2024 · Blood Cancer Journal · 32 citations
https://doi.org/10.1038/s41408-024-01043-5
Associations between IgG reactivity to Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) antigens and Burkitt lymphoma in Ghana and Uganda case-control studies
2018 · EBioMedicine · 22 citations
https://doi.org/10.1016/j.ebiom.2018.12.020
Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
2023 · Blood Cancer Journal · 18 citations
https://doi.org/10.1038/s41408-023-00882-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat